• RoundupsRoundups

    Euro Roundup: MHRA plans wave of medtech regulation after consultation shows support for reform

    The UK Medicines and Healthcare products Regulatory Agency (MHRA) is preparing to introduce a wave of regulations to reclassify medical devices, strengthen postmarket surveillance and otherwise revise its approach to medtech after seeing support for reform in the 891 responses to its 2021 consultation.   MHRA proposed a slate of medtech reforms considering the Cumberlege Review and the opportunity presented by Brexit. The proposals were intended to improve patient safe...
  • RoundupsRoundups

    Asia-Pacific Roundup: TGA adds chapters on SaMD, personalized devices to clinical evidence guidelines

    Australia’s Therapeutic Goods Administration (TGA) has updated its clinical evidence guidelines for medical devices, adding new chapters on software as a medical device (SaMD) and personalized medical devices (PMDs), prompted by regulatory frameworks launched in February 2021.   The PMD special topic describes the nature and type of clinical evidence that is needed to show the performance and safety of the devices, which are personalized for individual patients using t...
  • RoundupsRoundups

    Euro Roundup: EFPIA ‘deeply disappointed’ by COVID vaccine TRIPS waiver

    The World Trade Organization’s (WTO) agreement to a partial patent waiver for COVID-19 vaccines “sends a dangerous signal” to the pharmaceutical industry and all other innovative sectors, according to EFPIA, which expressed deep disappointment in the decision.   Twenty months after India and South Africa proposed an agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) on COVID-19 vaccine patents, WTO has finalized the terms of a deal that will a...
  • RoundupsRoundups

    Asia-Pacific Roundup: India proposes QR codes on key medicines within the year

    India’s Ministry of Health has revived a proposal to add bar codes or quick response (QR) codes to the packaging of 300 top medicines to facilitate product authentication. The requirement is set to come into force at the start of May 2023.   Proposals to include a barcode on drug packaging date back to 2015 when the Indian government released a draft proposal for consultation. The proposal was never finalized because many “pharmaceutical companies showed their inabilit...
  • RoundupsRoundups

    Euro Roundup: Generic manufacturers ask EU for inflation help

    Leaders at generic drug manufacturers including Sandoz, Teva and Viatris have written to European Union authorities to request actions that enable them to cope with “rampant cost inflation.”   In a letter published by the trade group Medicines for Europe, generic drug manufacturers make the case that the combination of inflation and “policies that continuously lower prices” is unsustainable. Inflation in Europe is above 7% for the first time in decades and the generic ...
  • RoundupsRoundups

    Asia-Pacific Roundup: PMDA outlines changes to project focused on medicine use in pregnancy

    Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has shared details of changes to a system for promoting the proper use of drugs for pregnant and breastfeeding women. The system went live last month to support the creation of a registry and the digitization of applications.   Officials created the Japan Drug Information Institute in Pregnancy (JDIIP) in 2005 to collect and review the latest evidence on the effects of medicines on mothers and fetuses. Using the...
  • RoundupsRoundups

    Euro Roundup: EFPIA warns of ‘critical challenges’ to starting clinical trials that use IVDs

    Sponsors operating in the EU face “critical challenges” when trying to set up clinical trials that require the use of an in vitro diagnostic (IVD), according to officials at EFPIA, who called on the European Commission to address the challenges to avoid damaging the local clinical trial environment.   In the statement, EFPIA (the European Federation of Pharmaceutical Industries and Associations) voiced its full support for the In Vitro Diagnostic Regulation (IVDR), whi...
  • RoundupsRoundups

    FDA Approvals Roundup: Priorix, Dupixent

    A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA).  New approval  Priorix okayed for preventing measles, mumps and rubella in patients aged 12 or older   GSK’s Priorix (measles, mumps and rubella vaccine, live) has been approved for active immunization for the prevention of measles, mumps and rubella (MMR) in individuals aged 12 months or older.  The efficacy of Priorix was demonstrated based on immunogenicity data ...
  • RoundupsRoundups

    Asia-Pacific Roundup: Philippine FDA consults on accelerated registration of WHO-prequalified products

    The Philippine Food and Drug Administration (FDA) is holding a consultation on its draft implementing guidelines on the collaborative procedure for the accelerated registration of World Health Organization (WHO)-prequalified pharmaceutical products and vaccines.   WHO issued a collaborative review procedure in 2013, and updated the text in 2016, to enable national regulatory agencies to leverage its scientific assessments to enhance their premarketing evaluation and re...
  • RoundupsRoundups

    Euro Roundup: Switzerland joins EU in bringing in new IVD requirements to improve patient safety

    The new ordinance on In vitro Diagnostic Medical Devices (IvDO) has come into force in Switzerland, bringing in stricter requirements for conformity assessment and post-market surveillance in an aim to improve patient safety.   Switzerland brought IvDO into force on 26 May, the same day as the In Vitro Diagnostic Regulation (IVDR) took effect across the border in the European Union. When Switzerland began work on IvDO, it enjoyed barrier-free mutual market access with ...
  • RoundupsRoundups

    FDA Approvals Roundup: Evrysdi, Kymriah, Tibsovo

    A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA).   New indications Evrysdi gets label extension for use in babies with spinal muscular atrophy Genentech’s Evrysdi ( risdiplam; powder for oral solution ) has been granted a new indication to include babies younger than 2 months with spinal muscular atrophy (SMA).   The approval is based on interim findings from the RAINBOWFISH study in newborns demonstrat...
  • RoundupsRoundups

    Asia-Pacific Roundup: TGA updates analytical, clinical performance requirements for seasonal influenza tests

    Australia’s Therapeutic Goods Administration (TGA) has updated its guidance on clinical performance requirements and risk mitigation strategies for seasonal influenza rapid antigen self-tests and combination tests. The second iteration of the guidance features more detailed analytical and clinical performance requirements.   TGA published the original guidance document in March 2021 to help manufacturers benefit from the change in the regulation of self-tests that happ...